|
1
|
Takahashi T, Saikawa Y and Kitagawa Y:
Gastric cancer: Current status of diagnosis and treatment. Cancers.
5:48–63. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Patel TN, Roy S and Ravi R: Gastric cancer
and related epigenetic alterations. Ecancermedicalscience.
11:7142017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gastric Cancer Treatment
(PDQ®): Health Professional VersionPDQ Cancer
Information Summaries. Bethesda, MD: 2002
|
|
4
|
Hu B, El Hajj N, Sittler S, Lammert N,
Barnes R and Meloni-Ehrig A: Gastric cancer: Classification,
histology and application of molecular pathology. J Gastrointest
Oncol. 3:251–261. 2012.PubMed/NCBI
|
|
5
|
Sikander M, Hafeez BB, Malik S, Alsayari
A, Halaweish FT, Yallapu MM, Chauhan SC and Jaggi M: Cucurbitacin D
exhibits potent anti-cancer activity in cervical cancer. Sci Rep.
6:365942016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang Y, Sun Y, Wu Y and Zhang J:
Cucurbitacin E inhibits osteosarcoma cells proliferation and
invasion through attenuation of PI3K/AKT/mTOR signaling. Biosci
Rep. Sep 21–2016.(Epub ahead of print). View Article : Google Scholar
|
|
7
|
Nakanishi T, Song Y, He C, Wang D, Morita
K, Tsukada J, Kanazawa T and Yoshida Y: Autophagy is associated
with cucurbitacin D-induced apoptosis in human T cell leukemia
cells. Med Oncol. 33:302016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ku JM, Kim SR, Hong SH, Choi HS, Seo HS,
Shin YC and Ko SG: Cucurbitacin D induces cell cycle arrest and
apoptosis by inhibiting STAT3 and NF-κB signaling in
doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells. Mol
Cell Biochem. 409:33–43. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hall JA, Seedarala S, Rice N, Kopel L,
Halaweish F and Blagg BS: Cucurbitacin D is a disruptor of the
HSP90 chaperone machinery. J Nat Prod. 78:873–879. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hudler P: Challenges of deciphering
gastric cancer heterogeneity. World J Gastroenterol.
21:10510–10527. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tran P, Nguyen C and Klempner SJ:
Targeting the Phosphatidylinositol-3-kinase pathway in gastric
cancer: Can omics improve outcomes? Int Neurourol J. 20 Suppl
2:S131–S140. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fang WL, Huang KH, Lan YT, Lin CH, Chang
SC, Chen MH, Chao Y, Lin WC, Lo SS, Li AF, et al: Mutations in
PI3K/AKT pathway genes and amplifications of PIK3CA are associated
with patterns of recurrence in gastric cancers. Oncotarget.
7:6201–6220. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Spear SA, Burns SS, Oblinger JL, Ren Y,
Pan L, Kinghorn AD, Welling DB and Chang LS: Natural compounds as
potential treatments of NF2-deficient schwannoma and meningioma:
Cucurbitacin D and goyazensolide. Otol Neurotol. 34:1519–1527.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cheng XJ, Lin JC and Tu SP: Etiology and
prevention of gastric cancer. Gastrointest Tumors. 3:25–36. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lui VW, Yau DM, Wong EY, Ng YK, Lau CP, Ho
Y, Chan JP, Hong B, Ho K, Cheung CS, et al: Cucurbitacin I elicits
anoikis sensitization, inhibits cellular invasion and in vivo tumor
formation ability of nasopharyngeal carcinoma cells.
Carcinogenesis. 30:2085–2094. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Marengo B, Nitti M, Furfaro AL, Colla R,
Ciucis CD, Marinari UM, Pronzato MA, Traverso N and Domenicotti C:
Redox homeostasis and cellular antioxidant systems: Crucial players
in cancer growth and therapy. Oxid Med Cell Longev.
2016:62356412016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Morry J, Ngamcherdtrakul W and Yantasee W:
Oxidative stress in cancer and fibrosis: Opportunity for
therapeutic intervention with antioxidant compounds, enzymes, and
nanoparticles. Redox Biol. 11:240–253. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu W, Yang Z and Lu N: Molecular targeted
therapy for the treatment of gastric cancer. J Exp Clin Cancer Res.
35:12016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ma G, Luo W, Lu J, Ma DL, Leung CH, Wang Y
and Chen X: Cucurbitacin E induces caspase-dependent apoptosis and
protective autophagy mediated by ROS in lung cancer cells. Chem
Biol Interact. 253:1–9. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ishii T, Kira N, Yoshida T and Narahara H:
Cucurbitacin D induces growth inhibition, cell cycle arrest, and
apoptosis in human endometrial and ovarian cancer cells. Tumour
Biol. 34:285–291. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen LD, Liu ZH, Zhang LF, Yao JN and Wang
CF: Sanggenon C induces apoptosis of colon cancer cells via
inhibition of No production, iNOS expression and ROS activation of
the mitochondrial pathway. Oncol Rep. 38:2123–2131. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vannini F, Kashfi K and Nath N: The dual
role of iNOS in cancer. Redox Biol. 6:334–343. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sasaki T and Kuniyasu H: Significance of
AKT in gastric cancer (Review). Int J Oncol. 45:2187–2192. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Almhanna K, Strosberg J and Malafa M:
Targeting AKT protein kinase in gastric cancer. Anticancer Res.
31:4387–4392. 2011.PubMed/NCBI
|
